MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
India has the second-largest number of adults with diabetes globally, after China
The company also raised Rs 270 crore investment from Temasek in 2019
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
It affects up to 10 per cent of women of reproductive age around the world
This facility will design & develop instruments, perform product reliability performance testing and verification
Strive to empower public health with disinfection robotics solutions in post-pandemic era
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
Subscribe To Our Newsletter & Stay Updated